Now, when you advertise a job on VetSurgeon.org, the system can send a message to all your employees (and any contacts in the profession) asking them to pass it on if they know anyone suitable, and to share the advertisement on their other social networks, such as Facebook.
As a further option, practices can also now offer a cash reward for a successful introduction leading to the post being filled. In that case, the message sent to employees and contacts lets them know that there’s a reward for their help.
VetSurgeon.org Editor Arlo Guthrie said: "Since we relaunched VetSurgeon Jobs, I’ve noticed a correlation between the number of times that job advertisements are shared by email or on Facebook, and the success that practices have in filling the vacancy.
"Of course, there is nothing to stop you emailing staff and contacts yourself, or offering a reward. But I suspect many don’t, and my hope is that this new feature will really help focus the mind, streamline the process and ultimately help you find the person who'll fit in with your team."
"Share & Reward is another feature exclusively available on VetSurgeon Jobs, alongside the VetSurgeon Locums Map and Find Our Jobs on VetSurgeon (a badge for your website that links to just your jobs).
"There's more on the way!"
Almost all rabies cases are as a result of being bitten by an infected dog, with around half of all dog bites and rabies deaths occurring in children under 15 years of age. Rabies, which is preventable, is categorised as one of the 17 Neglected Tropical Diseases by the World Health Organization (WHO).
The End Rabies Now campaign aims to significantly raise the profile of rabies as a global neglected tropical disease with policy makers and journalists, explaining what is being done to control and eliminate the disease. The campaign is led by Global Alliance for Rabies Control (GARC), and has three key messages:
Ahead of the tenth World Rabies Day, BVA has also recognised vet Professor Sarah Cleaveland OBE for her work in rabies control by awarding her the Chiron Award, one of the Association’s most prestigious awards for outstanding contributions to veterinary science.
Sarah said: "Awards like this are recognition of the contributions not only of one person, but the work of many. We are deeply committed to continuing our efforts towards the global elimination of canine rabies and tackling other zoonotic diseases that affect the health and livelihoods of many of the poorest people in the world."
The End Rabies Now campaign is based around the strong scientific evidence that vaccinating dogs is fundamental to disrupting the cycle of rabies transmission to humans. The target of 2030 was chosen because one of the UN’s sustainable development goals, launched in September 2015, includes the ambition to end by 2030 neglected tropical diseases such as rabies.
With 120 countries still affected by canine rabies, the End Rabies Now campaign advocates that collaborative cross-sector efforts are needed to end zoonotic diseases such as rabies: rabies elimination plans must include human and animal government agencies, veterinary and human health professionals, educators, scientists and community groups.
BVA President Gudrun Ravetz said: "The work being done worldwide by vets, human health professionals and others to combat this horrific disease that senselessly kills thousands each year is of the utmost importance and BVA is proud to support the End Rabies Now campaign and help get those key messages out to policy makers and governments worldwide – every rabies death is entirely preventable and we can end rabies by 2030 through vaccinating dogs."
The campaign will highlight things that can be done to help anxious pets, including getting professional advice from a behaviourist or trainer and using the company's products.
There's a marketing pack for practices, to help you educate owners and promote the month. It includes bunting, wall displays, posters, leaflets and gift vouchers for pet owners.
To raise awareness, Ceva will also be running a PR and advertising campaign together with a social media initiative in which owners will be encouraged to share their experience of having an anxious pet on Instagram and Facebook.
Abigail King, senior product manager at Ceva said: "It is widely known that humans suffer from anxieties, but pets do too with 82% of dogs and 89% of cats reported to be scared of something1.
"It is therefore important that we educate pet owners on the signs of stress and the help and support that they can give to their pets.
"Pet Anxiety Month will get people talking and we want people to know that there are products out there to support pets and that help is at hand to get the right advice, which is extremely important."
For further information, visit the Pet Anxiety Month website or follow the campaign on Instagram and Facebook. To request the Pet Anxiety Month marketing pack, email cevauk@ceva.com.
Reference
Delivered in a case-based style, the course will give students the chance to work through cases and apply practical theory before treating feline patients.
There are four modules: the consultation, further investigations, treatment, and post-operative and preventative care.
ICC says the emphasis is on providing practical skills that can be used in clinic.
On completion, students will have the confidence to identify a range of dental abnormalities, persuade cat owners to consent to further investigation and treatment, and formulate and carry out the ideal treatment plan for each cat.
Dr. Matthew Oxford BVM&S GPCert(SAS) MRCVS, who helped develop the course, said: "Dentistry is poorly represented in undergraduate veterinary courses, with feline specific dentistry perhaps only having one or two lectures, yet dentistry accounts for roughly 25% of all general surgery.
"This transformational course uses a very practical approach to case management taking vets from the initial consultation, through anaesthesia, dental radiography, surgery, and then postoperative care.
"Cases are worked through with extensive teaching material supplemented into cases to provide a pragmatic, case-based approach.”
Pre-registration for the course is available until 1st November with an early bird price of £299 (+VAT) available using the discount code NEWCBL50 at the checkout.
For more information, to check eligibility and prerequisites, and to sign up, visit https://bit.ly/3GpFXo4
For the first time BSAVA is running a Case Report Competition to be held at the annual Scottish BSAVA Congress (26-28th August 2011 at the Edinburgh Conference Centre).
Veterinary surgeons, nurses and students are invited to submit abstracts of no more than 400 words detailing a case and interesting discussion points.
Cases will then be selected for a short presentation at the congress
Successful selection will entitle the presenter to free congress registration on that day.
At the end of the session, a BSAVA manual of the winner's choice will be awarded to the case report deemed favourite by the audience.
Abstracts should be submitted via email by the 15 June 2011 and notification of acceptance will be given by the 30 June 2011.
Please send any enquires or submissions to Gerard McLauchlan (g.mclauchlan.1@research.gla.ac.uk) or Yvonne McGrotty (yvonne.mcgrotty@vets-now.com).
VetSurgeon member Viki Edmondson MRCVS is taking part in a drive to help 13-year-old Octavia Woodward, who was born with spinal muscular atrophy (SMA), raise £100,000 to help The SMA Trust.
Viki, a well-known vet in the carriage driving world, will be joining Octavia on 'Octavia's Mad Marathon', a five-day, 110 mile carriage drive from Windsor to Wincanton.
Octavia will be driving her pony, Diddy, with her mother Henrietta as co-driver. Meanwhile, Viki will be driving a pair of Gelderlander horses. They'll be leaving the main ring at the Royal Windsor Horse Show with a support crew at 3:30pm on 13th May.
Viki graduated from Bristol Veterinary School in 1993. Since 2001 she has run her own equine practice plus a small animal surgery from the Newdigate, Surrey farm she shares with husband Peter. Viki has known Octavia since she was born and it was Viki who paired up Diddy with Octavia and encouraged her to progress from walking round the roads to the excitement of "off-roading". Viki will be providing support and encouragement to Octavia during the trip - of course with any veterinary help being close by.
To support Viki and Octavia, visit: http://www.justgiving.com/vikithevet
Animalcare has announced that Buprecare buprenorphine single dose ampoules are now back in stock and ready to order from all veterinary wholesalers.
Production of the product had ceased in July 2011, when the company's previous manufacturer closed its sterile production unit.
Animalcare says that since then, it has been working to identify a reliable, high quality manufacturer which will be able to meet demand. The company has now signed a new contract with a German company which operates a substantial sterile injectables manufacturing facility in France. This facility is approved to manufacture Buprecare single dose ampoules and has produced, tested, quality assured and shipped its first batches.
Stephen Wildridge, CEO of Animalcare Group plc, said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly. However after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position. It’s a very good way to start 2013.”
Available in the familiar 5 x 1ml pack, the Buprecare single dose ampoules now have a ‘one-point-cut’ design giving greater assurance of a clean ‘snap’ when opening the ampoule, enhancing the safety of the user.
Additional support is also now available to veterinary practices that purchase Buprecare ampoules or multidose vials, including CPD pain management talks and a peer-reviewed pain assessment chart.
Ceva Animal Health has rebranded its nutraceutical supplements for cats and dogs under its Logic brand.
The new Logic range, which previously included the company's dental products, now includes Logic Diar-Stop (previously known as Diarsanyl Plus) for digestive health, Logic Flexivet, a joint supplement and Logic Senilife, a nutraceutical which Ceva says has been shown to manage the signs of brain ageing.
The range is available in consumer-friendly packaging and a merchandising unit is available to showcase the products in practice.
Claire Russell, consumer product manager at Ceva Animal Health said: "The new Logic range provides veterinary practices with an extensive portfolio of respected veterinary strength supplements and dental products, with more exciting and innovative products to come in the pipeline."
For further information on the Logic range, visit www.logicforpets.co.uk, contact your local Ceva Animal Health territory manager or call Ceva's customer support team on 01494 781510.
The company says there will be experts on hand to answer 'highly anticipated' questions about the new something.
In addition, Royal Canin Weight Management Specialists will be on the stand to help veterinary professionals tackle the number of overweight and obese cats and dogs in the UK.
The company says it'll be providing guidance and training opportunities for veterinary surgeons and vet nurses seeking support on obese and overweight pets, helping them to carry out thorough assessments and implement tailor-made treatment programmes.
As part of its continued support of the Guide Dogs charity, visitors to the stand will also be able to have a go at reading special kibble braille signs and get tips on making veterinary services more accessible.
BEVA Congress 2021 will now take place from September 4th-7th 2021.
The decision to cancel Congress 2020 was taken by BEVA Council and the Congress programme committee because of the unpredictable circumstances of the coronavirus pandemic.
Tim Mair, President of BEVA said: “The overriding factor in our decision-making process was to protect everyone attending Congress. We are chartering unknown territory at the moment and the additional planning requirements needed to run a large event like BEVA Congress with social distancing measures in place will take time.
“We intend for September 2021 to mark an exciting, fresh start for the profession following the harrowing experiences of 2020. It should be safe for our international speakers and delegates to attend by then, getting us all back on track with networking and world-class CPD to inspire us for the new post Covid-19 world.”
Tickets for BEVA Congress 2021 will be available later this year, more information from: www.bevacongress.org.
The new RUMA Companion Animal and Equine Group will initially focus on encouraging efforts to promote responsible antibiotic use.
Steve Howard, head of clinical services at the People’s Dispensary for Sick Animals and secretary general of the new group, said: "RUMA has spearheaded successful efforts to steward antibiotic use in farmed animals over the past five years, and we would like to see whether its principles can augment the considerable progress that’s already been made in the companion animal and equine sectors.
"The most notable of RUMA’s initiatives is the Targets Task Force, which has seen leading vets and farmers from each species working together with industry groups to develop meaningful goals for reducing, refining or replacing antibiotic use.
"Through establishing such proactive approaches towards antibiotic stewardship in companion animals and equines, we hope to optimise their health and welfare – as well as that of humans and the environment."
RUMA says that although total antibiotic sales are significantly lower for companion animals compared with the farming sector, even relatively low use can result in resistance to key medicines if good stewardship principles are not applied.
The collaboration will cover use of medicines in dogs, cats, rabbits, small mammals, exotic animals kept as pets, and equids. The aim is for the UK to lead the way in these sectors through evidence-based and measurable activities that will promote and enhance stewardship.
Gwyn Jones, chair of the new group (pictured right), said: "As a collaborative group we need to establish evidence-based protocols for reducing, replacing or refining antibiotic use in companion animals, to further help preserve and prolong the use of these vital tools for human and animal health.
“Efforts will be focused towards identifiable goals so that progress can be monitored and demonstrated. But we will also promote practical, practice-level resources, guidance and measures aimed at driving positive behaviour changes and protecting patients and practitioners alike."
Bluevac-3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3 for use in sheep and cattle.
Ceva says it reduces viraemia, prevents mortality and reduces the clinical signs of BTV-3 in sheep and reduces viraemia in cattle.
In sheep, Bluevac-3 can be administered from two months of age and two doses of 2ml should be administered subcutaneously three weeks apart.
In cattle, the vaccine can be administered from two months of age and two doses of 4ml should be administered three weeks apart.
Onset of immunity occurs 21 days/three weeks after completion of primary vaccination in cattle and sheep.
The vaccine can be used in pregnancy in cows and ewes.
No negative impact on milk-yield after using the vaccine in lactating ewes and cows is expected.
Ceva developed the new vaccine in partnership with vaccine manufacturer CZV Vaccines and launched it in Europe early in the summer, to mitigate the impact of the disease already experienced in the Netherlands, Belgium, and Germany.
Craig Wright, ruminant business unit director at Ceva Animal Health, said: “In co-operation with our partner, CZV Vaccines, we have worked tirelessly to bring Bluevac-3 to the UK to help fight bluetongue which has the potential to cause severe financial loss to farmers.
"The availability of an effective vaccine is an essential tool to help suppress future outbreaks by reducing viraemia, preventing mortality and reducing the clinical signs of BTV-3.”
Licences to allow the use of the new vaccine will either be geographically targeted general licences, initially in high risk counties as part of a phased approach, or specific licences which can be applied for through APHA.
General licencing will be subject to risk assessment.
https://www.gov.uk/government/publications/summary-of-product-characteristics-for-bluevac-3-btv-3-vaccine-in-the-uk.
Following a nationwide search to find the UK’s top veterinary professionals for 2009 and judged by an independent panel of experts, Petplan has announced the winners for the Veterinary Awards.
The Petplan Veterinary Awards recognise and applaud staff and practices throughout the country that have delivered an exceptional level of care to the nation’s pets, and their owners.
Simon Wheeler, Petplan’s Head of Marketing, explains: “Britain is known to be an animal-loving nation and with millions of households owning cats and dogs, pets play a central part in family life. The Petplan Veterinary Awards give us the opportunity to thank the veterinary profession for the outstanding level of care they provide to our animals.”
The winners of the 10th annual Petplan Veterinary Awards were:
VET OF THE YEARBen Jones, Ben Jones Veterinary Surgery, Chester, FlintshireBen’s understanding and compassion for his clients’ pets impressed the judges. Whilst being extremely knowledgeable, Ben can reassuringly explain the most complicated procedures to clients. Ben continuously goes above and beyond the call of duty, such as establishing a home visit scheme for pensioners and visiting a nursing home when an owner was there as a day patient.
VET NURSE OF THE YEARKaren McQuoid, The Old Golfhouse Veterinary Group, Watton, NorfolkThe judges believe Karen is an excellent role model for her team of nurses. Karen was noted for her positive attitude and good humour even under extreme pressure of being head nurse of four different practices.
VET RECEPTIONIST OF THE YEAR Yasmin Morowa, Melton Veterinary Surgery, Woodbridge, SuffolkYasmin’s attention to detail made her stand out as the winner of Vet Receptionist of the Year. Yasmin always checks to see how patients have progressed when she returns from holiday so she can help clients appropriately when they call or visit. Her kind approach makes her highly appreciated by both clients and colleagues.
VET PRACTICE OF THE YEAR St Clair Veterinary Group, Kirkcaldy, FifeSt Clair Veterinary Group was described as having exceptional customer care and uses every opportunity to educate their clients. The team stood out for their environmental consciousness.
Animalcare has launched Florgane, a novel, patented, long acting florfenicol 300mg/ml suspension which the company says has significant advantages over existing organic solvent-based florfenicol products on the market when used for the treatment and prevention of bovine respiratory disease (BRD).
Florgane is an aqueous, low viscosity advanced formulation, which, claims Animalcare, means that it is easier to inject even at temperatures as low as 5°C. Low temperature syringeability is important, as a large number of calves may need to be treated during colder weather at a time when the challenge from infectious agents is greatest. A syringeability study apparently demonstrated that Florgane is up to five times faster to administer when compared to the leading florfenicol non-aqueous formulation.
A paper on the treatment of naturally occurring respiratory disease with Florgane was presented recently at the British Cattle Veterinary Association (BCVA) Congress in Torquay. According to the company, the multi-centre field studies in Belgium, Germany and Italy, in over 400 cattle with bodyweights ranging between 73-180kg, demonstrated that Florgane given by a single intramuscular injection, at a 25% lower dose of 30mg/kg, is as efficacious as non-aqueous florfenicol 40mg/kg administered by subcutaneous injection, measured by treatment success and relapses.
Post mortem examination at day 27 (meat withdrawal of 37 days) confirmed that, despite being given via the intramuscular route, Florgane is well tolerated at the site of injection due to its aqueous base and physiological pH. Maximum volume per injection site is 15ml allowing calves up to 150kg to be treated.
Animalcare adds that a further advantage of Florgane is that it persists in plasma above the MICs for the three most common pathogens for significantly longer than conventional extended action 300mg/ml florfenicol solution preparations - thereby prolonging bacterial killing time. Therefore, owing to its improved bioavailability and excellent pharmacokinetics, Florgane can be given at an easy to remember dose of 1ml per 10kg.
Tony Liepman, Marketing Manager at Animalcare said: "Using Florgane will result in faster administration, resulting in less stress for the calves and a saving in time and money for the farmer."
Florgane is presented in polypropylene 100ml and 250ml multi-dose vials with a three year shelf-life.
For more information, visit www.animalcare.co.uk
From the beginning of October this year, the electronic recording of pig movements will be written into legislation.
Following a recent consultation, Defra intends to amend the existing Pigs, Records, Identification and Movements Order (PRIMO) 2007 to reflect the requirement of pre-notification of movements.
Dorothea Schiemann of BPEX said: "There will be a transitional period of six months for the phasing out of the paper-based AML2 forms, planned to start from 1 October 2011. This will give producers and businesses the opportunity to adjust to the change in process.
"From April 2012 the AML2 paper forms will cease to be a valid method of reporting movements. Pig movements will either have to be reported using the free eAML2 online service or the free eAML2 bureau service and there will also be third party agents such as marketing groups or the British Pig Association."
Following extensive trialling, the eAML2 system for farm to slaughter movements was launched in April 2011 across England and Wales. The functions for movements from farm to farm, market, collection centre and show, and for import and export, will be introduced in due course.
Benefits include the fact that the industry will have a realistic herd register providing accurate and timely information. This will enable better communication and control in the event of disease outbreak. There will be no need to fill in the same information again and again as the eAML2 service will pre-populate the basic information automatically. Also, when pigs are sent to slaughter, the system combines the movement licence and Food Chain Information (FCI) form in one, which will save producers time.
For more information and to register to use the system go to: http://www.eaml2.org.uk/
One set of guidelines deals with intoxication from pyrethrins commonly found in flea control products or ant powders, whilst the other covers macrocyclic lactone poisoning which most often occurs due to accidental ingestion of large animal anthelmintic products.
Both intoxications are commonly associated with severe neurological symptoms.
Will Peel, Product Manager at TVM UK said: "Our guidelines have proved very useful to veterinary staff and we have received requests from vets to add new guidelines for antiparasiticide intoxications. Our focus is on helping veterinary staff provide the best possible care for their patients so we hope that these new guidelines will prove beneficial."
The guidelines can be downloaded free from https://www.tvm-uk.com/vet-resource-library.
Advance25 Courses provide 25 hours of CPD in important areas of small animal practice, including Small Animal Medicine Cases Challenges, Emergency Medicine, Abdominal Ultrasound and Thoracic and Abdominal Radiology.
Advance25 courses run for a 6 week period, with tutor support. Recorded and live sessions are combined with discussion of multiple cases. Course materials are then accessible for 12 months.
Susie Coughlan, Managing Director of CPD Solutions said: "We appreciate that there is a high demand for quality online options at the moment, with many vets limited to online CPD.
"With the new Advance25 courses we’ve added more tutor support and ongoing interaction for those who are looking for a more immersive experience providing extended CPD hours. We’re really excited about these courses, which are launching now and running in the autumn. They should help vets make a real difference in their practices; they’re fully flexible and will fit with many people’s family and work commitments.’
For more information and to enter a prize draw to win a free Advance25 course, visit: https://www.cpd-solutions.com/advance25
The interviews give an insight into the career advice the interviewees got from their school, what steps they took to secure their place to study for their qualification, what hurdles they had to overcome and what can be done to address issues around the under-representation of some groups within the profession.
The College says the aim is to help inspire school age children to consider a veterinary career through frank conversations with role models who have chosen a vet or vet nursing career.
The first film is an interview with Rheanna Ellis, a 2021 Nottingham Vet School graduate who is now working as a veterinary surgeon at a West Midlands practice. In her interview she talks about her passion to become a vet from a young age, how she went about researching and preparing for her job, and the importance of perseverance.
To help promote the videos and the College’s ongoing work on diversity and inclusion, the RCVS has partnered with the official Black History Month campaign and website which will also be hosting the videos.
Many of the interviews have been carried out by Mandisa Greene, RCVS Senior Vice-President, who helped lead the RCVS Black History Month activities last year as the College’s first ever black President.
Mandisa said: “It’s important that we demonstrate commitment to diversity and inclusion and have a role in acknowledging and accentuating diverse voices within the professions. Throughout these video interviews I’ve had the opportunity to speak to some inspiring newly qualified and student veterinary professionals who are all clearly very passionate about supporting animal health and welfare.
“I hope that school children from all backgrounds who watch these videos will get the chance to see how rewarding and enjoyable a veterinary career can be and that they’ll be inspired to consider becoming a vet or vet nurse in the future.”
The RCVS will be publishing more video interviews on its YouTube channel through October and beyond.
Each charge related to fraudulent pet insurance claims that Mr Johnston had made for the treatment of animals when he was in practice in Banbridge, County Down, two of which were fictitious, and where he had arranged for the insurance claims to be diverted and paid into a personal bank account, rather than the practice’s bank account.
At an initial hearing, which concluded on April 2022, Mr Johnston had admitted all the charges against him as well as admitting that his conduct was dishonest and amounted to serious professional misconduct.
The Committee was satisfied that his conduct amounted to serious professional misconduct, with Committee Chair Paul Morris saying: “The Committee has no hesitation in concluding that the respondent’s dishonest conduct will have severely undermined the confidence of the public in the veterinary profession and, further, that his conduct fell far short of the standards and conduct properly to be expected of a member of the veterinary profession.
"The Committee is satisfied that this conduct by the respondent brought the profession into disrepute.”
The proceedings were then adjourned to allow a psychiatric report and other mitigation to be prepared.
At its resumed hearing in November 2022 the Committee considered what sanction to impose in relation to Dr Johnston’s actions.
At this point, the Committee decided to postpone its decision on sanction for a period of two years on the condition that Dr Johnston enter into undertakings to the Committee including refraining from any form of gambling, subjecting himself to a close regime of support and supervision, and repaying some of the sums he had defrauded.
The hearing reconvened in October 2024 to decide on an appropriate sanction.
The Committee noted that Mr Johnston had complied with the undertakings and provided the Committee with the interim reports required of him.
He also continued with the therapeutic interventions and programmes specified, as well as implemented measures designed to minimise the risk of a relapse into gambling.
The Committee also noted that reports from the gambling support services, to which Mr Johnston had signed up, all spoke positively about his involvements and confirmed the progress he had achieved in managing his addiction.
The Committee also took into account a psychiatric report as well as evidence under oath from Mr Johnston’s wife who confirmed his compliance with the undertakings.
As a result, the Committee was satisfied that the prospects of a repeat of the conduct which led to the charges laid against Dr Johnston were now greatly reduced.
The Committee said it was less impressed with the evidence provided by Mr Johnston.
While he had largely complied with the letter of the undertakings he gave in 2022, it remained troubled by his apparent unwillingness or inability, on account of lack of effort, to fulfil the assurances previously given that he was in the process of changing his name to Johnston, from Fegan, on official documentation in order to be consistent with his legal name, when he had not done so.
The only formal name change in place was on the RCVS Register, and he had failed to alter his name on his driver’s licence, on his registration with the Veterinary Council of Ireland, his passport, bank accounts, and one of his email addresses.
As a result, the Committee did not find Dr Johnston to be an entirely satisfactory witness.
Paul Morris, chairing the Committee and speaking on its behalf, said: “Having made the progress that he has over the period since the commission of the charges found proved in 2019, the Committee considers that the imposition of a sanction of suspension on top of the period of postponement would be excessive, in the particular circumstances of this case.
“For the same reasons, as stated above, it is considered that it would be excessive now to impose a sanction of removal from the register.
“That process of reasoning has driven the Committee to the conclusion that the sanction of a reprimand and warning as to future conduct is what the facts and circumstances of this case call for.
"That is because the respondent can be under no illusion about the outcome were he to appear again before this Committee.
"A failure to take advantage of the exceptional course adopted by this Committee on this occasion would be regarded as a serious aggravating factor were he to appear before the Committee at any time in the future.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
The College says the reforms will make for a clearer and more streamlined process, and offer an alternative, more compassionate way of resolving cases that might otherwise go to a full Disciplinary Committee hearing.
The College will now establish ‘Stage 1 Preliminary Investigation Committees (PICs)’ to replace the current Case Examiner Group stage of the concerns investigation process.
Eleanor Ferguson, RCVS Registrar, said: “Setting up Stage 1 PICs will streamline and clarify the early stages of the concerns investigation process and could also potentially, once sufficiently bedded in, reduce the amount of time taken for a number of cases.
“Currently, Stage 1 of a concerns investigation is carried out by a Case Examiner Group who determine if there is an ‘arguable case’ for serious professional misconduct before referring it on to the Preliminary Investigation Committee.
"However, under these reforms, the Stage 1 PICs will close cases where there is no realistic prospect of finding a case of serious professional misconduct.
"Where cases require formal statements and/or expert opinion they will be referred on to Stage 2 PIC to determine if, based on the additional evidence gathered, a case is serious enough to warrant referral to either the Charter Case Committee [see below], or a full, public Disciplinary Committee hearing.
“In essence this change means that there will be one consistent threshold of seriousness in all our investigations, meaning it is likely that fewer cases will be unnecessarily referred to Stage 2 of the process.”
The second reform involves the implementation of the new ‘Charter Case Protocol’ to provide an alternative way to resolve suitable cases meeting certain criteria which, though they meet the threshold to go to the Disciplinary Committee, it is considered that the public interest can still be served without a full hearing.
The ‘Charter Case Committee’ to which these cases will be referred will be able to issue written warning notices.
Eleanor added: “The establishment of the Charter Case Protocol and Committee is important for the RCVS in being able to get the balance right between upholding professional conduct standards and protecting animal health and welfare and public confidence in the professions, while also being a compassionate regulator.
“The type of cases we envisage being dealt with by the Committee are those where the conduct of the veterinary surgeon or veterinary nurse has fallen far short of what is expected of them under the Code, but where there is no ongoing risk to animal welfare or public confidence, and where the level of insight and contrition about their conduct is such that it can be resolved without the need for an onerous, stressful and expensive Disciplinary Committee hearing.
"We estimate that the Charter Case Committee will deal with around 20 such cases per year.
“Of course, the most serious cases of professional misconduct, for example around dishonesty and criminality, will continue to be referred to Disciplinary Committee hearings.
“It is worth noting that Charter Case Protocol and Committee are working titles, describing the fact that we are implementing this process under the remit of our Royal Charter.
"RCVS Council has agreed that the name should be changed in due course to something that better reflects its function and remit."
Unlike the Disciplinary Committee, the Charter Case Committee will not issue to the press the full details of cases as a news article.
Instead, it will publish a warning notice on the RCVS website summarising the area of concern, the relevant sections of the Code that were breached and supporting guidance it referred to, and the reasons for issuing the warning.
These warning notices will remain on the RCVS website for a maximum of two years and will not change the registration status of the individual.
The College says that the reforms are likely to take some months to implement and it will be looking to recruit additional Preliminary Investigation Committee members in due course.
There are 10 candidates standing this year and vets can vote for up to three of them until 5pm on Friday 21st April 2023:
The biographies and statements for each candidate are available at www.rcvs.org.uk/vetvote23 where each candidate has also answered two questions of their choice submitted by members of the profession.
The three candidates who receive the most votes will take up their four-year terms on RCVS Council at the RCVS Annual General Meeting on Friday 7th July 2023.
Any veterinary surgeons who have not received their voting email should contact CES directly on support@cesvotes.com stating which election they intend to vote in.
New research amongst veterinary professionals conducted by CEVA Animal Health, manufacturer of D.A.P.® and Feliway®, has revealed that pet owners may be unintentionally fuelling their pets' noise phobias in the run up to the fireworks' season.
According to CEVA's research, up to 95% react inappropriately, for example petting an anxious pet during firework exposure rather than making an effort to ignore the fireworks, thereby reassuring the animal by behaving normally.
The research also suggested that 77% of clients have never taken action to address their pets' noise phobias as fireworks' season is only an annual occurrence. This is despite evidence that noise phobias can affect pets all year round and tend to become worse over time.
In addition, if owners do seek advice from their vet for noise phobias, it is at the last minute. It is estimated that 46% of clients leave it until the day before the fireworks are due to start before seeking help.
Lucy Brett, product manager at CEVA Animal Health said: "Owners are not doing enough to reduce their pets' firework fears and prevent noise phobias from developing.
"Taking early, proactive action within the practice is the best way to help dogs with pre-existing firework phobias as well as those with mild fears which, if left untreated, may develop into more serious noise phobias."
CEVA Animal Health and Sound Therapy 4 Pets have once again joined forces with the Association of Pet Behaviour Counsellors (APBC), Feline Advisory Bureau (FAB) and PDSA to launch a 'Remember, remember your pets this November' campaign to provide owners with advice on how to look after their pets during the firework season and the precautions they should take to help them cope with their fear of fireworks.
The initiative features a wide range of advice including how to use synthetic copies of natural pheromones, D.A.P. ® and Feliway®, to help comfort and reassure fearful pets, creating a comforting den for dogs to retreat to during firework exposure and treating noise phobias using behavioural therapy with the Sounds Scary desensitisation CD (which is the only behavioural therapy product for noise phobias supported by the RSPCA).
For further information, please visit www.petfireworkfear.co.uk.
The Animal Medicines Distributors Association (AHDA) and the Animal Medicines Training Regulatory Authority (AMTRA) have both come out against the BVA's call for all anthelmintic medicines to be reclassified as POM-V, which would prevent them being prescribed by Suitably Qualified Persons (SQP).
Ian Scott, Secretary General of AHDA, said that instead of launching an attack on SQPs, the BVA should be working with them and animal owners to tackle anthelmintic resistance: "The BVA has written to the VMD to ask that all anthemintics be classified to POM-V only. This will monopolise the supply and distribution of anthelmintics for vets only. It effectively places the blame for anthelmintic resistance squarely on SQPs.
"An attempt by BVA to create a division between vets and SQPs demonstrates that the BVA is out of touch with its members.
"Both prescribing channels must work together to tackle the problem and AHDA has been working hard with vets at national and local level to ensure customers receive consistent, high quality, up-to-date and relevant advice from both channels.
"What is worrying is that the BVA attack also infers that farmer producers and equine owners are incapable of making decisions that not only affect their livelihood but cast doubt on their ability to care for their animals' welfare."
Meanwhile, Stephen Dawson, Secretary General of AMTRA said: "The large majority of SQPs deal with parasite control on a daily basis, having trained and been examined to a syllabus developed with BVA input. SQPs have to undertake compulsory continuing professional development, the majority of which includes good practice in parasite control. Therefore AMTRA has every confidence that qualified SQPs have excellent knowledge of parasitology to advise their clients on the correct choice and use of anthelmintics.
"It is important to recognise the hard work, knowledge and dedication of thousands of SQPs throughout the UK. The implication of what BVA say is that they are laying a proportion of the blame for resistance to these medicines at the door of SQPs. But the evidence isn't there: countries in Europe and elsewhere with different prescription systems, mainly though vet-only channels, still have major resistance problems. Prescription of antimicrobials by veterinary surgeons hasn't prevented concerns about prescribing practices and developing resistance. The key point is good advice from the prescriber and how they are then used in practice, rather than who prescribes them. The challenge for us all is not just to seek excellence in prescribing but also in usage on farm, something SQPs are ideally placed to do with their frequent farmer contact.
"I would urge all parties to work in partnership to ensure that best practice in prescription and use is followed by all prescribers and users. It is up to all prescribers to act responsibly, but to single out one group over another is unjustified. A pseudo-monopoly by vets on supply would do nothing to help farmers in difficult times."
Mr Dawson also expressed doubts about permanent POM-V status for new livestock anthelmintics: "While we fully support VMD's and VPC's need to be sure that the risk associated with wider availability of a new product is low, AMTRA considers that the current division in distribution classes and consequent low uptake of the newer products means that the much bigger risk is that widespread reliance on the three aging classes may be followed by reliance on just the two new classes when the older classes become unusable. Much better to have responsible prescription of all five classes now, by appropriately trained SQPs, vets and pharmacists, to ensure that there is a prospect of long term availability of effective parasite control."